sEphB4-HSA in Treating Participants With BCG-Unresponsive or Refractory Bladder Cancer

NCT03552796 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Budget issues

Conditions

Recurrent Bladder Carcinoma
Bladder Cancer Stage 0
Bladder Cancer Stage I

Interventions

OTHER: Pharmacokinetic Study
BIOLOGICAL: Recombinant EphB4-HSA Fusion Protein

Sponsor

University of Southern California

Collaborators

[object Object]